BindingDB logo
myBDB logout

19 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
23218714 14 Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere.EBI Vanderbilt University School Of Medicine
22546206 162 Synthesis and evaluation of¿-lactam analogs of PGE2 as EP4 and EP2/EP4 agonists.EBI Minase Research Institute
15357992 81 Discovery of new chemical leads for prostaglandin D2 receptor antagonists.EBI Minase Research Institute
22386979 104 Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists.EBI Minase Research Institute
22119471 64 Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity.EBI Minase Research Institute
22204740 135 Synthesis and evaluation of novel modified¿-lactam prostanoids as EP4 subtype-selective agonists.EBI Minase Research Institute
21885288 109 Design and synthesis of new prostaglandin D2 receptor antagonists.EBI Minase Research Institute
21737285 138 Discovery of selective indole-based prostaglandin D2 receptor antagonist.EBI Minase Research Institute
20385498 115 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs.EBI Minase Research Institute
20346663 76 Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists.EBI Minase Research Institute
20004584 57 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 1: discovery and exploration of the carboxyamide side chain.EBI Minase Research Institute
20129791 120 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. part 2: optimization of the side chains to improve in vitro and in vivo potencies.EBI Minase Research Institute
15341946 92 Discovery of orally active prostaglandin D2 receptor antagonists.EBI Minase Research Institute
11454474 84 Design and synthesis of a highly selective EP4-receptor agonist. Part 2: 5-thia and 9beta-haloPG derivatives with improved stability.EBI Minase Research Institute
11454473 119 Design and synthesis of a highly selective EP4-receptor agonist. Part 1: 3,7-dithiaPG derivatives with high selectivity.EBI Minase Research Institute
11454472 107 Design and synthesis of a highly selective EP2-receptor agonist.EBI Minase Research Institute
12192085 52 Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.BDB Case Western Reserve University